Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Thermo Fisher Opens New Bioprocessing Center in St. Louis | Contract Pharma

What are you searching for?

Sign in
Breaking News

Thermo Fisher Opens New Bioprocessing Center in St. Louis

Combines bioproduction and pharma services businesses to accelerate innovation and enhance productivity for biopharma companies.

By: Contract Pharma

Contract Pharma Staff

Thermo Fisher Scientific Inc. has opened its new Bioprocessing Collaboration Center (BCC) in St. Louis, MO.

The facility is adjacent to the company’s biologics manufacturing facility, which recently doubled production capacity with a $50 million expansion. The combined bioproduction and pharma services businesses aims to accelerate innovation and enhance productivity for biopharma companies, enabling them to meet the growing need for more flexible, scalable biologics development and manufacturing solutions.

In 2019, four in 10 drugs in development were biologics, driving demand for innovative development and manufacturing solutions. The BCC will bring together the company’s GMP biologics manufacturing with its bioprocessing technologies including bioreactors, cell culture media, chromatography and analytical tools, among others. This collaboration aims to deliver new single-use bioprocessing technologies as well as drive critical process, data management and quality improvements that enable scale-up solutions for biopharma customers.

“Our St. Louis site is among the world’s largest producers of biologics using single-use technology and the ideal location for this unique collaboration,” said Michael Shafer, senior vice president and president, pharma services, Thermo Fisher Scientific. “These complementary businesses will work together to develop innovative bioprocessing technologies, products and services. This will enhance bioprocess workflows and enable our customers to take their products to market faster and with greater efficiency.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics